Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections

This study has been completed.
Institut National en Santé Publique du Québec
Centre de Recheche du Centre Hospitalier Université Laval
SmithKlinBeecham Biologicals
Information provided by (Responsible Party):
Vladimir Gilca, Laval University Identifier:
First received: September 13, 2005
Last updated: May 24, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)